The donation is the largest single one of its kind the hospital received in 2017 and the largest single year gift to South Nassau by the Feil Family Foundation.
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
1.5M Gift Supports South Nassau Cancer Center Consolidation
1. For Immediate Release February 26, 2018
Contact: Damian Becker, Manager of Media Relations
(516) 377-5370
South Nassau Receives $1.5 Million from Feil Family Foundation
--Major Gift Supports Hospital’s Plan to Establish Comprehensive Cancer Center
Oceanside, NY – The Louis Feil Charitable Lead Annuity Trust has made a $1.5 million
donation to South Nassau Communities Hospital to help relocate the hospital’s cancer program
services and departments to a dedicated, centralized comprehensive cancer center that will be
based on the hospital’s main campus in Oceanside (NY).
The donation is the largest single one of its kind the hospital received in 2017 and the
largest single year gift to South Nassau by the Feil Family Foundation. The donation will allow
South Nassau to continue work toward consolidating all cancer services at the Oceanside
campus, which will greatly benefit cancer patients.
Presently, the hub of South Nassau’s cancer program, the Gertrude & Louis Feil Cancer
Center, is located in Valley Stream (NY), while a range of other essential services, including
imaging, diagnostic, support and counseling to radiation therapy and chemotherapy, are located
in several different areas of the hospital as well as at various hospital satellite facilities situated
throughout the South Shore of Nassau County. This coordinated, yet de-centralized, network of
cancer services can be an inconvenience and logistically challenging for patients and their
families.
“I thank Mr. (Jeffrey) Feil, the Feil family, and trustees of the Trust for their ongoing
commitment to South Nassau’s mission,” said Richard J. Murphy, President and CEO at South
Nassau. “This gracious gift will be instrumental to South Nassau’s continued drive to provide
the most accessible, compassionate cancer care that Long Island residents deserve and need.”
The Feil family has gifted more than $6.5 million to South Nassau in the past several
years. This includes a $3 million donation to South Nassau in the spring of 2011that supported
the continued growth and expansion of the Gertrude & Louis Feil Cancer Center and a $1
million dollar donation made last spring will also benefit the cancer program consolidation plan.
News From:
2. “I have a very genuine and deep admiration for all the work that the team at South
Nassau does each and every day,” said Mr. Jeffrey J. Feil. “It is gratifying to know that the Trust
continues to play an integral role in South Nassau’s cancer care services and helps hundreds of
residents across the South Shore have convenient access to world-class clinicians and advanced
treatments that give them the inspiration they need to fight a cancer diagnosis.”
Mr. Feil, his sisters, and their families, including their parents, the late Gertrude and
Louis, have been lifelong residents of Rockville Centre, NY. Feil serves as President & CEO of
The Feil Organization, a family-owned real estate investment, development and management
company based in New York, NY.
Treating approximately 1,500 patients annually, South Nassau’s cancer program is one of
the region’s premiere providers of compassionate advanced cancer care. It has received the
prestigious American College of Surgeons (ACS) Commission on Cancer Outstanding
Achievement Award on three consecutive occasions since 2009. The national mark of
excellence is awarded to eligible ACS accredited cancer programs every three years and reflects
clinical process performance and patient outcomes which are among the best in the United
States.
The cancer program has a new chemotherapy treatment center and is equipped with three
of the most effective technologies used to treat and eradicate cancer: the Varian Novalis Tx™, da
Vinci® Surgical System and Gamma Knife® Perfexion. In addition to The Gertrude & Louis
Feil Cancer Center, the program incorporates the following specialty cancer care services:
• GYN Oncology Department (Valley Stream)
• Long Island Gamma Knife® Center (Oceanside)
• Center for Prostate Health Program (Oceanside)
• Center for Breast Health (Oceanside)
• Center for Lung Health (Oceanside/Valley Stream)
• Radiation Oncology Department (Oceanside and Valley Stream)
• Surgical Oncology Department (Oceanside and Valley Stream)
• Complete Women’s Imaging Center at South Nassau (Oceanside)
• PET/CT Service (Oceanside)
Designated a Magnet® hospital by the American Nurses Credentialing Center (ANCC)
for outstanding nursing care, South Nassau® Communities Hospital is one of the region’s largest
hospitals, with 455 beds, more than 900 physicians and 3,500 employees. Located in Oceanside,
NY, the hospital is an acute-care, not-for-profit teaching hospital that provides state-of-the-art
care in cardiac, oncologic, orthopedic, bariatric, pain management, mental health and emergency
services.
3. In addition to its extensive outpatient specialty centers, South Nassau provides
emergency and elective angioplasty, and offers Novalis Tx™ and Gamma Knife® radiosurgery
technologies. South Nassau operates the only Trauma Center on the South Shore of Nassau
County verified by the American College of Surgeons as well as Long Island’s only free-
standing, 9-1-1 receiving Emergency Department in Long Beach. South Nassau is the only
hospital on Long Island in 2018 to achieve Healthgrades America’s 100 Best Hospitals for
Orthopedic Surgery™, Orthopedic Surgery Excellence Award™ and 5-star rating for Total Hip
Replacement, and it was one of just two hospitals on Long Island to achieve Healthgrades 5-stars
in Hip Fracture Treatment.
South Nassau also is a designated Stroke Center by the New York State Department of
Health and Comprehensive Community Cancer Center by the American College of Surgeons,
and is an accredited center of the Metabolic and Bariatric Surgery Association and Quality
Improvement Program.
In addition, the hospital has been awarded the Joint Commission’s gold seal of approval
for disease-specific care for hip and knee replacement, heart failure, bariatric surgery, wound
care and end-stage renal disease. For more information, visit www.southnassau.org.
-30-